Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

4th Annual Investigator Initiated Studies Conference Set for May 19-20 in Dusseldorf, Germany


Print article Print article
2014-03-14 15:33:27 - Ensuring ROI, Developing IIS Strategy, Protecting Intellectual Property Ownership Among New Session Topics

(Chicago, IL) – For the fourth straight year, Q1 Productions will be hosting the European Investigator Initiated Studies Conference in Dusseldorf, Germany, providing attendees with the most valuable insight to the forecast of the IIS industry. This year’s conference will offer nearly a dozen new session topics addressing the entire process of investigator research, from reviewing proposals and understanding how to best align research with the goals of the corporation to methods for closing out studies and handling publication data, all while maintaining strict adherence to legal and regulatory frameworks on an international playing field.

This year, the IIS Conference will include session topics covering the biggest concerns within the industry, such as monitoring multi-centered IISs, ensuring ROI, establishing a publication

plan, as well as practical IIS case studies. Guest speakers, including Alexander Kostek of Pfizer, Joelle Rebetez of Actelion Pharmaceuticals, and Dominique Devos of Norgine will conduct in-depth and collaborative sessions and interactive panel discussions on several issues and challenges that are top-of-mind to medical and clinical affairs professionals within the healthcare space.

“This conference allows attendees to review the whole process in order to improve Return On Investment by working on strategy, outcomes, adherence to timelines and regulations while making sure not to take any sponsor responsibilities,” said Dr. Dominique Devos, session speaker and Medical Advisor at Norgine.

By popular request, the conference, specially catering to pharmaceutical and medical device companies, will have more focus on legal aspects of external physician collaboration, a bigger focus on ROI, and more speakers from the pharmaceutical industry. The conference will offer an intimate setting to foster more peer-to-peer networking opportunities and promote discussion amongst industry professionals, as well as tailored sessions to accommodate pharmaceutical and medical device companies of all sizes.

For more information about the Investigator Initiated Studies Conference or to register for the meeting, please visit www.q1productions.com/euiis.

Follow us @Q1Productions #Q1euiis


Media Contact:
Erica Abdnour
Q1 Productions
eabdnour@q1productions.com
(312) 955-0729

About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.


Contact Information:
Q1 Productions

500 N. Dearborn
Suite 500
Chicago, IL 60654

Contact Person:
Erica Abdnour

Phone: 312.602.9683
email: email

Web: www.q1productions.com/



Author:
Paul Hernandez
e-mail
Web: www.q1productions.com
Phone: 3126029684

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com